## **Core Concept**
Therapeutic Drug Monitoring (TDM) is a clinical practice used to manage drugs with a narrow therapeutic index, ensuring efficacy while minimizing toxicity. It involves measuring plasma drug concentrations to adjust dosing regimens. For TDM to be clinically useful, specific pharmacokinetic and pharmacodynamic criteria must be met.

## **Why the Correct Answer is Right**
The correct answer, , implies that a drug must have a narrow therapeutic index, and its plasma concentration should correlate with both efficacy and toxicity. A narrow therapeutic index means the difference between the therapeutic dose and the toxic dose is small. TDM helps in maintaining drug levels within this narrow range. The relationship between plasma concentration and clinical effect or toxicity is crucial for TDM to guide dosing adjustments effectively.

## **Why Each Wrong Option is Incorrect**
- **Option A:** A wide therapeutic index does not necessitate TDM since the risk of toxicity is low even at high doses, making monitoring less critical.
- **Option B:** While correlation with efficacy is important, if there's no clear link to toxicity, TDM might not prevent harm.
- **Option D:** Predictable pharmacokinetics is beneficial but not a primary criterion for TDM; it's more about the drug's therapeutic index and the correlation of its levels with effects and side effects.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that drugs with a narrow therapeutic index, such as digoxin, phenytoin, and lithium, are prime candidates for TDM. This practice helps in optimizing therapy and reducing the risk of adverse effects.

## **Correct Answer:** .